Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rani Therapeutics Holdings (RANI) Revenue (2020 - 2025)

Historic Revenue for Rani Therapeutics Holdings (RANI) over the last 5 years, with Q1 2025 value amounting to $172000.0.

  • Rani Therapeutics Holdings' Revenue changed N/A to $172000.0 in Q1 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year increase of 19259.26%. This contributed to the annual value of $1.0 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Rani Therapeutics Holdings reported Revenue of $172000.0 as of Q1 2025.
  • Rani Therapeutics Holdings' Revenue's 5-year high stood at $2.0 million during Q2 2021, with a 5-year trough of -$1.3 million in Q3 2023.
  • Over the past 4 years, Rani Therapeutics Holdings' median Revenue value was -$517500.0 (recorded in 2023), while the average stood at -$146000.0.
  • In the last 5 years, Rani Therapeutics Holdings' Revenue soared by 316833.33% in 2021 and then surged by 17932.1% in 2024.
  • Quarter analysis of 4 years shows Rani Therapeutics Holdings' Revenue stood at $2.0 million in 2021, then crashed by 166.09% to -$1.3 million in 2023, then surged by 179.32% to $1.0 million in 2024, then tumbled by 83.27% to $172000.0 in 2025.
  • Its last three reported values are $172000.0 in Q1 2025, $1.0 million for Q4 2024, and -$1.3 million during Q4 2023.